Fresh analysis reveals that people who discontinue popular weight-loss injections like Mounjaro or Wegovy may regain lost weight far faster than those who stop traditional lifestyle programs.
Published data in a leading medical journal demonstrates that while obese people often shed substantial amounts of their body weight while on the medication, the mass is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"Users buying these treatments should be aware of the risk of fast weight regain when the therapy ends," stated researcher Dr. Susan Jebb.
This pace of regain implies a return to pre-treatment weight in about a year and a half.
Weighing Approaches
The research, which reviewed dozens of trials involving thousands of participants, compared the results of GLP-1 agonists with conventional dieting.
Researchers point out that individuals who shed pounds through diet and exercise generally experience a less rapid creep back—around 100 grams monthly—once they finish.
Understanding the Fast Regain
Doctors propose the way of the injections explains the amplified regain.
GLP-1 drugs imitate a natural hormone called GLP-1, which controls feelings of fullness.
"Sustained high doses of the hormone concentrations far above than normal might result in the body to generate a reduced amount of its own natural GLP-1, and may also diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this medication results in hunger is unsuppressed, making binge eating a significant risk."
An Ongoing Issue?
The NHS recommend the injections for individuals with weight-linked health risks, accompanied by recommended diet and exercise modifications.
A number of clinicians contend that, given the likelihood of weight regain, the therapy is often ongoing.
This perspective is reinforced by pharmaceutical companies, who note that the results "underscore the long-term nature of excess weight," comparing it to managing conditions like hypertension.
User Experiences
Individuals who have discontinued the jabs explain a intense resurgence of appetite.
"It was like a switch flipping and you're instantly starving," described one woman.
This difficulty is compounded if individuals have not adopted permanent dietary or behavioural modifications during therapy.
Growing Interest
Survey data indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with desire remaining high.
- Use is greater among females compared to males.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion access the drugs through private prescriptions rather than public health services.
Ultimately, researchers emphasize that while the jabs are effective agents for weight loss, they are not a magic fix and lasting health benefits hinges on integrated lifestyle management.
